BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valashedi MR, Najafi-Ghalehlou N, Nikoo A, Bamshad C, Tomita K, Kuwahara Y, Sato T, Roushandeh AM, Roudkenar MH. Cashing in on ferroptosis against tumor cells: Usher in the next chapter. Life Sci 2021;285:119958. [PMID: 34534562 DOI: 10.1016/j.lfs.2021.119958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao Z, Zheng S, Kamei K, Tian C. Recent progress in cancer therapy based on the combination of ferroptosis with photodynamic therapy. Acta Materia Medica 2022;1. [DOI: 10.15212/amm-2022-0025] [Reference Citation Analysis]
2 Valashedi MR, Roushandeh AM, Tomita K, Kuwahara Y, Pourmohammadi-Bejarpasi Z, Kozani PS, Sato T, Roudkenar MH. CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability. Life Sci 2022;304:120704. [PMID: 35714703 DOI: 10.1016/j.lfs.2022.120704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Valashedi MR, Bamshad C, Najafi-Ghalehlou N, Nikoo A, Tomita K, Kuwahara Y, Sato T, Roushandeh AM, Roudkenar MH. Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters. Hum Cell 2022. [PMID: 35415781 DOI: 10.1007/s13577-022-00699-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]